Showing 1 - 10 of 17
Persistent link: https://www.econbiz.de/10012312799
Persistent link: https://www.econbiz.de/10011299236
Persistent link: https://www.econbiz.de/10011297629
Objectives: To estimate the cost savings and health benefits in the UK NHS that could be achieved if human milk usage in the NICU was increased. Methods: A systematic review established the disease areas with the strong sources of evidence of the short, medium and long-term benefits of human...
Persistent link: https://www.econbiz.de/10011587181
Persistent link: https://www.econbiz.de/10012098904
Persistent link: https://www.econbiz.de/10011947497
Objective: To estimate the pharmacoeconomic impact for the French Social Security System of preventing recurrent acute rhinopharyngitis (RARP) in at-risk children with OM-85 BV, an immunostimulating agent indicated for the prevention of recurrences. Design: A decision-analysis model. The...
Persistent link: https://www.econbiz.de/10005243125
Background:Background: Attention-deficit hyperactivity disorder (ADHD) is a common psychiatric disorder in childhood, affecting 3-7% of school-age children in the US and imposing substantial economic burden. Stimulants are considered first-line pharmacological treatment and are the most...
Persistent link: https://www.econbiz.de/10010556689
The potential benefits of influenza vaccination programmes targeted at children have gained increasing attention in recent years. We conducted a literature search of economic evaluations of influenza vaccination in those aged ≤18 years. The search revealed 20 relevant articles, which were...
Persistent link: https://www.econbiz.de/10010556696
While pneumococcal conjugate vaccines have shown to be highly effective against invasive pneumococcal disease, their potential effectiveness against acute otitis media (AOM) might become a major economic driver for implementing these vaccines in national immunization programmes. However, the...
Persistent link: https://www.econbiz.de/10010614297